previous compound ID: 641 next compound
InChIKey: FTLDJPRFCGDUFH-UHFFFAOYSA-N
SMILES: CC(C)(CC1=CC=CC=C1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC2=CC=CC=C2

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "E Matthes" "D Rotin" "R Robert" "SD Macknight" "JW Hanrahan" "B Kus" "J Goepp" "J Liao" "GW Carlile"

chemical graph of compound 641





CID is 4621
synonyms found at PubChem are:
Oxethazaine, Oxetacaine, 126-27-2, Mucaine, Oxaethacainum, Oxethacaine, Oxaine, Betalgil, Muthesa, Stomacain, Topicain, Oxethacaina [Italian], Tepilta, Oxetacainum [INN-Latin], Oxetacaina [INN-Spanish], UNII-IP8QT76V17, CCRIS 4692, EINECS 204-780-5, FH 099, WY 806, BRN 2404063, CHEMBL127592, IP8QT76V17, CHEBI:31947, Wy-806, Oxetacaine (INN), Oxetacaine [INN], 2,2'-((2-Hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide), NCGC00016382-01, CAS-126-27-2, 2-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol, DSSTox_CID_5818, N,N-Bis(N-methyl-N-phenyl-tert-butylacetamido)-beta-hydroxyethylamine, 2,2'-((2-Hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methylacetamide), Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-, DSSTox_RID_77936, DSSTox_GSID_25818, Milzine, Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(alpha,alpha-dimethylphenethyl)-N-methyl-, Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-, 2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide, N-(1,1-dimethyl-2-phenyl-ethyl)-2-[[2-[(1,1-dimethyl-2-phenyl-ethyl)-methyl-amino]-2-oxo-ethyl]-(2-hydroxyethyl)amino]-N-methyl-acetamide, SR-05000001851, Oxethazaine [USAN:JAN], storocaine, Storocain, Prestwick_767, degrees centEuEuOo, Spectrum_001657, AC1L1IKS, Prestwick0_000058, Prestwick1_000058, Prestwick2_000058, Prestwick3_000058, Spectrum2_001987, Spectrum3_001751, Spectrum4_000202, Spectrum5_001269, cid_4621, Oxethazaine (JP17/USAN), SCHEMBL24489, BSPBio_000215, BSPBio_003482, KBioGR_000803, KBioSS_002137, 4-12-00-02822 (Beilstein Handbook Reference), MLS002154188, DivK1c_000715, SPECTRUM1503279, SPBio_002136, SPBio_002173, BPBio1_000237, Oxethazaine, analytical standard, DTXSID0025818, HMS502D17, KBio1_000715, KBio2_002137, KBio2_004705, KBio2_007273, KBio3_002702, KS-00000GVG, FTLDJPRFCGDUFH-UHFFFAOYSA-N, MolPort-003-666-480, NINDS_000715, 13930-31-9 (hydrochloride), HMS1568K17, HMS1922A04, HMS2093C15, HMS2095K17, HMS2236A03, HMS3370M13, HMS3712K17, Pharmakon1600-01503279, BCP07626, HY-B0955, ZINC3874585, Tox21_110407, 2622AH, BDBM50017672, CCG-39525, LS-703, NSC758444, AKOS024284189, Tox21_110407_1, API0003711, CS-4432, DB12532, MCULE-5155939580, NSC-758444, IDI1_000715, NCGC00016382-02, NCGC00016382-03, NCGC00016382-04, NCGC00016382-07, NCGC00095039-01, NCGC00095039-02, NCGC00095039-03, AN-43561, CC-33412, SMR001233479, ST073363, SBI-0051816.P002, AB00052348, FT-0603332, C12552, D01152, AB00052348_08, AB00052348_09, 126O272, C-22674, J-005353, SR-05000001851-1, SR-05000001851-3, BRD-K56940463-001-05-4, BRD-K56940463-001-08-8, 2-Hydroxyethyliminobis[N-(alpha,alpha-dimethylphenethyl)-N-methyl-acetamide], 2,2'-((2-hydroxyethyl)imino)bis(N-alpha,alpha-dimethylphenethyl)-N-methylacetamide, 2,2'-(2-hydroxyethylazanediyl)bis(N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide), 2-Hydroxyethyliminobis[N-(alpha,alpha-dimethylphenethyl)-N-methyl- acetamide], 2-oCOO>>uNC degrees +/->>uE<<(N-[|A,|A- paragraph signthorn(1/4)x>>u+/-(1/2)OO>>u]-N-(1/4)x>>uOOo pound degrees .), N-(1,1-Dimethyl-2-phenyl-ethyl)-2-[{[(1,1-dimethyl-2-phenyl-ethyl)-methyl-carbamoyl]-methyl}-(2-hydroxy-ethyl)-amino]-N-methyl-acetamide, N-(1,1-dimethyl-2-phenylethyl)-2-({[N-(1,1-dimethyl-2-phenylethyl)-N-methylcar bamoyl]methyl}(2-hydroxyethyl)amino)-N-methylacetamide